Fortress Biotech, Inc. FBIOP 深滬

交易中 08-26 09:46:45 美东时间

7.5757

0.000

0.00%

華盛通

立即下載

最高7.57
今開7.57
成交量 1股
最低 7.57
昨收 7.5757
總市值 3.82亿
52周最高 9.49
市盈率 ^靜 --
換手率 0.00%
52周最低 4.72
委比 37.61%
總股本 5046.32万
歷史最高 20.5506
量比 0.05
振幅 0.00%
歷史最低 -1.5766
每手 1
風險率 0.97%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Fortress Biotech shares are trading higher after the company reported better-than-expected Q2 sales results.

Fortress Biotech shares are trading higher after the company reported better-th...

08-16 00:36
Fortress Biotech Q2 EPS $0.45 Beats $(0.36) Estimate, Sales $16.413M Beat $14.534M Estimate

Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $(0.36) by 225 percent. This is a 161.64 percent increase over losses of $(0.73) per share from

08-15 04:27
AstraZeneca’s Anselamimab Trial Shows Mixed Results

Fortress Biotech ( ($FBIO) ) has shared an update. On July 16, 2025, AstraZenec...

07-17 05:48
Fortress Biotech Reveals AstraZeneca's Anselamimab Trial Did Not Achieve Statistical Significance

-SEC Filing

07-17 05:31
Fortress Biotech Reports Q1 2025 Financial Highlights

Fortress Biotech Inc ( ($FBIO) ) has released its Q1 earnings. Here is a breakd...

05-20 11:57
Fortress Biotech Q1 EPS $(0.48) Beats $(0.49) Estimate, Sales $13.14M Beat $11.62M Estimate

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.49) by 2.04 percent. This is a 53.85 percent increase over losses of $(1.04) per share from

05-16 04:31
Fortress Biotech Board Member Resigns for New Role

An announcement from Fortress Biotech ( ($FBIO) ) is now available. On April 15...

04-17 04:50
Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges

Fortress Biotech Inc (($FBIO)) has held its Q4 earnings call. Read on for the m...

03-29 08:15
Fortress Biotech FY 2024 Earnings Preview

Fortress Biotech (NASDAQ:FBIO) is scheduled to announce FY earnings results on Wednesday, March 26th, after market close. The consensus EPS Estimate is -$3.28 (+61.3% Y/Y) and the consensus Revenue Es...

03-26 05:35
India's Sun Pharma buys onco-derma firm Checkpoint Therapeutics for $355M

India's pharma giant Sun Pharma to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted oncology company—for an upfront cash payment of $355M. The deal involves an upfront cash ...

03-10 13:56

派息除權日	每股總股息	派息日期
2024-06-14	0.20	2024-06-30
2024-05-14	0.20	2024-05-31
2024-04-12	0.20	2024-04-30
2024-03-14	0.20	2024-03-31
2024-02-14	0.20	2024-02-29
2024-01-11	0.20	2024-01-31
2023-12-14	0.20	2023-12-31
2023-11-14	0.20	2023-11-30
2023-10-12	0.20	2023-10-31
2023-09-14	0.20	2023-09-30
2023-08-14	0.20	2023-08-31
2023-07-13	0.20	2023-07-31
2023-06-14	0.20	2023-06-30
2023-05-12	0.20	2023-05-31
2023-04-13	0.20	2023-04-30
2023-03-14	0.20	2023-03-31
2023-02-14	0.20	2023-02-28
2023-01-12	0.20	2023-01-31
2022-12-14	0.20	2022-12-31
2022-11-14	0.20	2022-11-30
2022-10-13	0.20	2022-10-31
2022-09-14	0.20	2022-09-30
2022-08-12	0.20	2022-08-31
2022-07-14	0.20	2022-07-31
2022-06-14	0.20	2022-06-30
2022-05-12	0.20	2022-05-31
2022-04-13	0.20	2022-04-30
2022-03-14	0.20	2022-03-31
2022-02-14	0.20	2022-02-28
2022-01-13	0.20	2022-01-31
2021-12-14	0.20	2021-12-31
2021-11-12	0.20	2021-11-30
2021-10-14	0.20	2021-10-30
2021-09-14	0.20	2021-09-30
2021-08-12	0.20	2021-08-30
2021-07-14	0.20	2021-07-30
2021-06-14	0.20	2021-06-30
2021-05-13	0.20	2021-05-30
2021-04-14	0.20	2021-04-30
2021-03-12	0.20	2021-03-31
2021-02-11	0.20	2021-02-28
2021-01-14	0.20	2021-01-31
2020-12-14	0.20	2020-12-31
2020-11-12	0.20	2020-11-30
2020-10-14	0.20	2020-10-31
2020-09-14	0.20	2020-09-30
2020-08-20	0.20	2020-08-31
2020-07-17	0.20	2020-07-31
2020-06-12	0.59	2020-06-30
2020-03-13	0.59	2020-03-31
2019-12-12	0.59	2019-12-31
2019-09-12	0.59	2019-09-30
2019-06-13	0.59	2019-07-01
2019-03-14	0.59	2019-03-31
2018-12-13	0.59	2018-12-31
2018-09-13	0.59	2018-09-30
2018-06-14	0.59	2018-06-30
2018-03-14	0.59	2018-03-30

公司名稱	Fortress Biotech, Inc.
行業分類	Pharmaceuticals: Major
業務描述	Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Fortress Biotech, Inc. FBIOP 深 滬

7.5757

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Fortress Biotech, Inc. FBIOP 深滬